MENU
VOR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Vor Biopharma (VOR) Earnings Date & Reports

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases... Show more

A.I. Advisor
published Earnings

VOR is expected to report earnings to fall 28.92% to -82 cents per share on November 11

Vor Biopharma VOR Stock Earnings Reports
Q3'26
Est.
$-0.82
Q2'26
Missed
by $0.43
Q1'26
Missed
by $5.01
Q4'25
Beat
by $84.98
Q3'25
Missed
by $121.50
The last earnings report on August 11 showed earnings per share of -115 cents, missing the estimate of -73 cents. With 546.84K shares outstanding, the current market capitalization sits at 1.08B.